Cookie settings

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use natcan.org.uk, remember your settings and improve our services.

We also use cookies set by other sites to help us deliver content from their services.

View cookies
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Skip to main content
National Cancer Audit Collaborating Centre logo
  • About NATCAN
  • Our impact
  • Patient and Public Involvement
  • News
  • Events
  • FAQs
  • Audits
  • Data dashboards
  • Reports
  • Library
  • Quality Improvement
  • Bowel
  • Kidney
  • Lung
  • Metastatic Breast
  • Non-Hodgkin Lymphoma
  • Oesophago-Gastric
  • Ovarian
  • Pancreatic
  • Primary Breast
  • Prostate
    • Bowel
    • Kidney
    • Lung
    • Metastatic Breast
    • Non-Hodgkin Lymphoma
    • Oesophago-Gastric
    • Ovarian
    • Pancreatic
    • Primary Breast
    • Prostate
  • Data dashboards
  • Reports
  • Library
  • Quality Improvement
  • About NATCAN
  • Our impact
  • Patient and Public Involvement
  • News
  • Events
  • FAQs
  1. Home
  2. Audits
  3. National Oesophago-Gastric Cancer Audit (NOGCA)

NOGCA FAQs

On this page

  1. About NOGCA
  2. Methodology and Reporting

For more information about NATCAN, the data we use, participation in the audits, and audit reporting, please visit our general FAQs here.

About NOGCA

The National Oesophago-Gastric Cancer Audit (NOGCA) measures the quality and outcomes of care for people with oesophageal or gastric cancer in NHS Trusts in England and Health Boards in Wales, with the goal to improve the quality of care provided.

The Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP), funded by NHS England and the Welsh Government. 

The Audit involves a wide range of professionals and organisations that collaborate to ensure its effectiveness. The core group is the NOGCA Project Team, which works in close consultation with its own Clinical Reference Group and a Patient & Public Involvement Forum to integrate expert and patient perspectives.
Beyond these groups, the Audit is a partnership between several organisations; the Healthcare Quality Improvement Partnership (HQIP) commissions the Audit, funding is provided by NHS England and the Welsh Government. The National Cancer Audit Collaborating Centre (NATCAN), which is part of the Royal College of Surgeons of England’s Clinical Effectiveness Unit, is responsible for delivering the Audit and managing the data.

Methodology and Reporting

The Audit includes all people with a first diagnosis of primary oesophageal or gastric cancer within the specified reporting period in England or Wales. Included patients must be:

1) Diagnosed with malignant neoplasm of the oesophagus or stomach, identified via ICD-10 codes C15 or C16
2) Adults, aged 18 or older
3) Have a record of a histological diagnosis of an epithelial tumour

The following people are excluded from the Audit:
• People diagnosed with non-epithelial tumours
• People diagnosed with neuroendocrine tumours
• People diagnosed via death certificate only
• People who were neither diagnosed nor treated within the constituent country of interest

Please see section 3 of the NOGCA SotN Methodology Supplement 2025 for full inclusion/exclusion criteria.

Please see section 5 of the NOGCA SotN Methodology Supplement 2025 for full information.

Please see section 7.2 of the NOGCA SotN Methodology Supplement 2025 for full information.

Share this page

National Cancer Audit Collaborating Centre logo

Sign up for updates from NATCAN

Subscribe

Follow NATCAN

HQIP
Royal College of Surgeons of England
  • Contact
  • Accessibility
  • Privacy
  • Cookies
  • Terms and conditions
  • Working with us

Copyright © 2026 National Cancer Audit Collaborating Centre

Lovingly crafted by Mixd